Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasm

Explore clinical trials studying Urinary Bladder Neoplasm. Study availability and eligibility vary by location and protocol.

15 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasm trial results

Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

NCT05786716

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +61 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT04442724

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Cedars-Sinai Medical Center (CSMC) Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Harvard School of Medicine/Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

NCT03785925

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations
  • San Francisco VA Medical Center - NAVREF - PPDS San Francisco, California, United States
  • Innovative Clinical Research Institute, LLC Whittier, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 70 locations
View Trial Details

Related conditions